Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Lara Goldstein

Reunion Neuroscience Presents Q2 2023 Financial Results & Pipeline Update

Psychedelics biopharma company Reunion Neuroscience Inc. (NASDAQ:REUN) reported its business update and fiscal results for the second quarter ended September 30, 2022.

Reunion’s president and CEO Greg Mayes stated that the company has consolidated as an independent company and is “well positioned to round out the year in preparation for what promises to be an exciting 2023.” 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.